13F Holdings
中文EN

ATXI AVENUE THERAPEUTICS, INC.

Pharmaceutical Preparations · OTC · SEC CIK 1644963 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY25.6%
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-160.0%
ROA-106.0%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets104.9%
Debt / equity—
Current ratio—
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.79x
Accruals ratio-22.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY2023*2023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.40M$0———
R&D expense$1.04M$6.64M$6.13M$2.70M$1.25M
SG&A expense$3.65M$4.64M$4.18M$5.34M$2.48M
Operating income-$3.08M-$11.28M-$14.54M-$8.04M-$3.74M
Income tax$2,000$0$0$0—
Net income-$2.91M-$11.65M-$10.38M-$3.55M-$3.73M
EPS (basic)-0.93-15.79-73.48-1.63-0.22
EPS (diluted)————-0.22
Weighted avg. shares (diluted)———2.19M1.13M
Balance sheet
Cash & equivalents$2.85M$2.59M$1.78M$6.71M$3.76M
Current assets————$3.96M
Total assets$2.93M$2.67M$1.85M$6.84M$3.96M
Current liabilities$1.10M$816,000$1.20M$3.58M$509,000
Total liabilities$1.10M$816,000$1.20M$3.58M$509,000
Shareholders' equity$1.83M$2.80M$1.58M$3.90M$3.45M
Shares outstanding3.18M2.11M341,3244.77M1.41M
Cash flow statement
Operating cash flow-$1.83M-$9.03M-$9.45M-$7.60M-$3.75M
Investing cash flow—$0-$3.00M$0—
Financing cash flow$2.09M$9.84M$7.53M$10.54M$4.38M
Stock-based compensation$665,000$1.24M$906,000$649,000$442,000
Share buybacks——$0$1.10M—

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.